Cargando…
Surrogate cytokine agonists: promising agents against COVID-19
Autores principales: | Lin, Zemin, Zuo, Jianping, He, Shijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072766/ https://www.ncbi.nlm.nih.gov/pubmed/35523768 http://dx.doi.org/10.1038/s41392-022-01015-w |
Ejemplares similares
-
A promising vaccine candidate against COVID-19
por: Wang, Xiwei, et al.
Publicado: (2020) -
FcγRIIb blockage: a promising immunotherapy target for severe COVID-19
por: He, Xuemei, et al.
Publicado: (2021) -
Azvudine (FNC): a promising clinical candidate for COVID-19 treatment
por: Yu, Bin, et al.
Publicado: (2020) -
Constrained surfaces: promising therapeutic targets for COVID-19 determined by systematically mutational analysis
por: Wang, Manni, et al.
Publicado: (2021) -
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
por: Abd El-Aziz, Tarek Mohamed, et al.
Publicado: (2020)